Pharmaceutical Industry Articles & Reports - Page 25

Updated April 2026: Million-dollar gene therapy pricing analysis covering Casgevy, Lyfgenia, Lenmeldy, Elevidys (with 2025 safety update), the Roctavian and Beqvez market withdrawals, and CMS's 2025 Cell and Gene Therapy Access Model. Compares one-time cure costs to lifetime chronic care using value-based pricing, ICER QALY thresholds, and outcomes-based contracts.

Analysis of how Large Language Models (LLMs) automate clinical evidence collection for HTA economic dossiers. Covers systematic reviews, data extraction, and ch

Learn how patient quality of life (QoL) data is quantified into Quality-Adjusted Life Years (QALYs) to perform cost-effectiveness analysis for specialty drugs.

How real-world data (RWD) and evidence (RWE) validate clinical trial assumptions in post-market economic models. Updated April 2026 with EU JCA, DARWIN EU, FDA finalized RWE guidance, ICH M14 and EHDS developments.

Learn how health economic data like cost-effectiveness analysis is used to secure drug formulary placement and reimbursement from payers and HTA bodies.

Learn the integrated workflow for manufacturing deviations, CAPA, and change control in GMP. This guide covers regulatory requirements and common inspection pit

An educational guide to biologics comparability studies. Learn how to prove "no meaningful change" after manufacturing process changes, based on ICH Q5E and FDA

Learn how Integrated Business Planning (IBP) and S&OP help pharma supply chains align demand, capacity, inventory, and constraints. Updated April 2026 with GLP-1 demand and capacity planning, FDA RMP guidance, biosimilar wave 2, and AI in IBP.

Learn how MES and Electronic Batch Records (EBR) improve pharma manufacturing. This guide explains benefits for GMP compliance, data integrity, and review-by-ex

Learn the key differences between US DSCSA and EU FMD for pharmaceutical serialization. This guide covers compliance requirements for ops teams, including data

A proven framework for CDMO selection in pharma and biotech, with scorecards, due diligence checklists, and governance KPIs — updated April 2026 with BIOSECURE Act, Catalent/Novo deal, and EU GMP Annex 1 impacts.

Learn the critical steps for successful pharmaceutical technology transfer. This guide covers the R&D to CDMO process, key documents, and how to avoid scale-up

Learn to deploy private LLMs in pharma. This guide covers compliant architecture, including on-premise & cloud, and navigating HIPAA, GxP, and FDA regulations.

Learn how Generative AI (GenAI) applies to Medical Affairs in pharma. This guide covers key use cases, compliance guardrails, and the risks of using LLMs.

Learn about the FDA's AI guidance for drug development. This article explains the 7-step credibility framework, context of use (COU), and risk-based approach.

An in-depth guide to Veeva X-Pages development. Learn how to create custom, contextual dashboards in Vault CRM using HTML, JavaScript, and the DataService API.

Explore Andon Labs' profile and its Project Vend collaboration with Anthropic. Learn how autonomous AI agents using LLMs are benchmarked for business tasks.

Get a detailed list of biotech companies in Toronto (2026). Learn about the life sciences ecosystem, top startups in AI and genomics, and key industry players.

An in-depth analysis of the build vs. buy decision for a quality management system (QMS) in biotech startups. Explore costs, timelines, and compliance factors.

Navigate FDA 21 CFR Part 11 for AI systems. This article details compliance strategies for validation, audit trails, and data integrity in regulated GxP setting

Explore how AI Contract Lifecycle Management (CLM) software streamlines biotech contract workflows, ensures regulatory compliance, and accelerates clinical tria

Compare the IEC 62304 standard vs. FDA CSA guidance for medical software. Learn key differences in scope, risk classification, validation, and documentation.

Understand the FDA's final Computer Software Assurance (CSA) guidance, a risk-based shift from CSV for pharma & biotech. Learn key principles for compliance.

Learn how to integrate GAMP 5 (2nd Ed.) and FDA's final Computer Software Assurance (CSA) guidance (Sept 2025, updated Feb 2026). Shift from CSV to risk-based validation.